CONSA Update: “Newborn screening for sickle cell disease in Africa” Article

CONSA Update: “Newborn screening for sickle cell disease in Africa” Article

Posted on


The Consortium of Newborn Screening in Africa (CONSA), launched in 2016 to address the global burden of SCD, shows the value of newborn screening and how it can be implemented in diverse settings throughout sub-Saharan Africa. This American Society of Hematology (ASH) supported consortium aims to introduce standard-of-care practices for screening and early-intervention therapies at participating institutions, screening 10,000 –16,000 babies per year in Kenya, Ghana, Liberia, Nigeria, Uganda, Tanzania, and Zambia and providing clinical follow-up for babies who test positive for the disease. This recent Lancet Haematology article entitled, “Newborn screening for sickle cell disease in Africa,” provides further detail on this work and current achievements.

Leave a Reply

Your email address will not be published. Required fields are marked *

Name *

This site uses Akismet to reduce spam. Learn how your comment data is processed.